Other OTC - Delayed Quote • USD
CaliPharms, Inc. (KGET)
As of April 18 at 3:55 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Brian Wayne Geer | Secretary and Director | -- | -- | 1980 |
| Mr. Bo Linton | President & Chairman | -- | -- | 1970 |
| Mr. Eric Watson | Chief Executive Officer | -- | -- | 1969 |
| Ms. Maxine Pierson | Executive VP In Charge of Mergers & Acquisitions and Member of Advisory Board | -- | -- | -- |
CaliPharms, Inc.
33175 Temecula Parkway
Suite A 8019
Temecula, CA 92592
United States
Description
CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.
Corporate Governance
CaliPharms, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available